Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.05p
   
  • Change Today:
    -0.18p
  • 52 Week High: 5.13
  • 52 Week Low: 3.00
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 976,045
  • Market Cap: £16.27m

Eden Research fungicide added to German organics list

By Josh White

Date: Wednesday 11 Dec 2024

LONDON (ShareCast) - (Sharecast News) - Sustainable biopesticides and biocontrol specialist Eden Research announced on Wednesday that its flagship fungicide Mevalone has been added to the Organic Input List by FiBL Germany - a key certification for products used in organic farming.
The AIM-traded firm said the inclusion followed the approval of Mevalone in Germany earlier in the year.

It said the Organic Input List is managed by the Research Institute of Organic Agriculture (FiBL), an organisation focussed on sustainability and organic farming standards.

The certification confirmed that Mevalone met stringent requirements for use in organic production across Germany and several other countries.

Eden said the registration aligned with Germany's 2030 organic strategy, which aimed to increase organic farmland to 30% by the end of the decade - exceeding the EU Green Deal target of 25%.

Mevalone could play a pivotal role in helping German farmers meet those goals while maintaining productivity, the company explained, by providing effective control of fungal diseases in compliance with organic standards.

"Mevalone's inclusion in the Organic Input List by FiBL Germany provides us with another vital organic registration in an important market, following in the footsteps of Greece, Italy, and France," said chief executive officer Sean Smith.

"Our products' organic compliance demonstrates their sustainable qualities based on Eden's terpene chemistry, as well as their strong efficacy, even when compared with conventional pesticides."

Smith said Germany currently had about 10% of its apple orchards and 15% of vineyard areas dedicated to organic farming, adding that indications were that the proportions of organic farmland were growing rapidly.

"Against this backdrop, we have strategically positioned Mevalone as one of the leading alternative fungicide products that fits both the conventional and organic farming needs."

At 1100 GMT, shares in Eden Research were up 3.9% at 4p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 3.05p
Change Today -0.18p
% Change -5.43 %
52 Week High 5.13
52 Week Low 3.00
Volume 976,045
Shares Issued 533.35m
Market Cap £16.27m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
7.3% below the market average7.3% below the market average7.3% below the market average7.3% below the market average7.3% below the market average
10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average
Price Trend
57.8% below the market average57.8% below the market average57.8% below the market average57.8% below the market average57.8% below the market average
10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average
Income Not Available
Growth
53.40% above the market average53.40% above the market average53.40% above the market average53.40% above the market average53.40% above the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average

Eden Research Dividends

No dividends found

Trades for 13-Mar-2025

Time Volume / Share Price
16:12 72,166 @ 3.03p
15:28 305 @ 3.10p
11:17 400,000 @ 3.08p
11:11 400,000 @ 3.08p
10:54 8,000 @ 3.00p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page